Regenerx Biopharmaceuticals Inc (RGRX)
0.0014
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Regenerx Biopharmaceuticals Revenue (Quarterly): 0.0192M for March 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 0.0192M |
December 31, 2022 | 0.0192M |
September 30, 2022 | 0.0192M |
June 30, 2022 | 0.0192M |
March 31, 2022 | 0.0192M |
December 31, 2021 | 0.0192M |
September 30, 2021 | 0.0192M |
June 30, 2021 | 0.0192M |
March 31, 2021 | 0.0192M |
December 31, 2020 | 0.0192M |
September 30, 2020 | 0.0192M |
June 30, 2020 | 0.0192M |
March 31, 2020 | 0.0192M |
December 31, 2019 | 0.0192M |
September 30, 2019 | 0.0192M |
June 30, 2019 | 0.0192M |
March 31, 2019 | 0.0192M |
December 31, 2018 | 0.0192M |
September 30, 2018 | 0.0192M |
June 30, 2018 | 0.0125M |
March 31, 2018 | 0.0188M |
December 31, 2017 | 0.0174M |
September 30, 2017 | 0.0139M |
June 30, 2017 | 0.0127M |
March 31, 2017 | 0.0127M |
Date | Value |
---|---|
December 31, 2016 | 0.0127M |
September 30, 2016 | 0.0127M |
June 30, 2016 | 0.0127M |
March 31, 2016 | 0.0552M |
December 31, 2015 | 0.0101M |
September 30, 2015 | 0.0055M |
June 30, 2015 | 0.005M |
March 31, 2015 | 0.04M |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | 0.0295M |
December 31, 2012 | 0.2809M |
September 30, 2012 | 0.2954M |
June 30, 2012 | 0.5417M |
March 31, 2012 | 0.2248M |
December 31, 2011 | 0.2894M |
September 30, 2011 | 0.0312M |
June 30, 2011 | 0.5886M |
March 31, 2011 | 0.6025M |
December 31, 2010 | 0.7957M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0192M
Minimum
Mar 2020
0.0192M
Maximum
Dec 2019
0.0192M
Average
0.0192M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -0.3852M |
Total Expenses (Quarterly) | 0.3241M |
EPS Diluted (Quarterly) | -0.2683 |